Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...

With Admelog Sanofi hopes to to turn the tables on Eli Lilly – in partnership with Boehringer Ingelheim the US pharma has stolen market share in the longer-acting insulin market with a cheaper ...

Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

Our mantra is to ignore short term noise and focus on long term valuation. But with the election of Donald Trump as the 47th ...

KEY POINTS Chronic rhinosinusitis refers to symptomatic inflammation of the nose and paranasal sinuses that has been present ...

With 2025 underway, the AFS Health Care team highlights some of the most pressing legal issues facing the health care industry this year.

Sanofi Consumer Healthcare India Q4 Results 2025:Sanofi Consumer Healthcare India declared their Q4 results on 20 Feb, 2025. The topline decreased by 20.53% year-over-year (YoY), with profit ...

(RTTNews) - French drug major Sanofi (SNYNF, SNY) announced Wednesday that it has signed the share purchase agreement for the sale of a 50% controlling stake in its consumer healthcare business ...

Dupilumab is being jointly developed by Regeneron and Sanofi under a global collaboration agreement. In addition to the currently approved indications, Regeneron and Sanofi are studying dupilumab ...

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.